Innovative Tool may Predict Best Glucose-Lowering Drugs for Type 2 Diabetes: Lancet Dr. Kamal Kant Kohli6 May 2025 8:00 AM ISTResearchers at the University of Exeter have developed a tool to identify the most effective glucose-lowering drugs for individuals with type 2...
Ultrasound-Guided Radiofrequency Ablation Shows Promise for Treating Aldosterone-Producing Adenomas: Study Dr Riya Dave25 April 2025 8:15 PM ISTA recent study suggests that ultrasound-guided radiofrequency ablation (EUS-RFA) may be an effective and safe treatment option for...
Gepotidacin could be new treatment option for gonorrhea, suggests Phase 3 trial Jacinthlyn Sylvia21 April 2025 8:30 AM ISTA new study published in the journal of The Lancet showed that, with no new safety issues, gepotidacin showed no inferiority to ceftriaxone with...
Clopidogrel Outperforms Aspirin in Reducing Cardiovascular Events Post-PCI: SMART-CHOICE 3 Trial Medha Baranwal19 April 2025 8:45 AM ISTSouth Korea: The SMART-CHOICE 3 trial demonstrated that in patients who had completed the standard course of dual antiplatelet therapy (DAPT)...
In triple-vessel disease, CABG and PCI not significantly different at five years: Lancet Dr. Kamal Kant Kohli16 April 2025 8:30 AM ISTIn sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they underwent open-heart bypass...
Genetic therapy gives infants life-changing improvements in sight: Lancet Dr. Kamal Kant Kohli15 April 2025 8:45 PM ISTFour young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through UCL Institute...
Less frequent mammograms non-inferior to annual mammograms in breast cancer patients over 50 years: Study Jacinthlyn Sylvia11 April 2025 3:30 AM ISTA new study published in the journal of The Lancet showed that occasionally performed mammograms were not inferior to yearly mammograms for breast...
Semaglutide Boosts Walking Capacity in PAD and Type 2 Diabetes, STRIDE Trial Finds Medha Baranwal3 April 2025 9:15 AM ISTUSA: The STRIDE trial has demonstrated that semaglutide significantly enhances walking capacity in individuals with peripheral artery disease (PAD)...
Atosiban for Preterm Birth: Prolongs labour but not Neonatal outcomes, finds study Dr. Shravani Dali24 March 2025 10:00 PM ISTResearchers have found that while the tocolytic drug atosiban prolonged labor in cases of threatened preterm birth beyond 30 weeks, it did not improve...
Contraction inhibitors after 30 weeks have no effect on baby's health, reveals research Dr. Kamal Kant Kohli7 March 2025 8:15 PM ISTThe use of tocolytic drugs in cases of threatened premature birth after 30 weeks of pregnancy does not improve the baby's health. This is shown by the...
GLP-1 drug shows little benefit for people with Parkinson's disease: Study Dr. Kamal Kant Kohli2 March 2025 9:30 PM ISTThe GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL...
Medical Bulletin 27/ February/ 2025 Dr. Bhumika Maikhuri27 Feb 2025 3:00 PM ISTHere are the top medical news for the day:Predicting Future Health: Organ Age Biomarkers Foretell Disease Risk Decades EarlyOur organs age at...
